Sunday, December 3, 2023
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Social & Behavioral Science

New study using confidential drug prices demonstrate how disease severity impact drug coverage decisions

June 29, 2022
in Social & Behavioral Science
0
Share on FacebookShare on Twitter

In a new study from the University of Bergen (UiB), confidential drug prices have been used to evaluate coverage decisions for new drugs in Norway.

Eirik Tranvåg

Credit: Eirik Tranvåg

In a new study from the University of Bergen (UiB), confidential drug prices have been used to evaluate coverage decisions for new drugs in Norway.

High costs of new drugs are a global challenge, and countries have different systems to negotiate prices and evaluate new drugs. In Norway, drug appraisals are guided by three priority setting principles: health benefit, resource use and disease severity.

“Confidential drug prices have traditionally been hindering research on drug approvals, and we are therefore thrilled that we have gained access to the confidential prices in our study”, says Eirik Joakim Tranvåg who is first author of the new study.

In the UiB study, all drug decisions in the Norwegian specialized health care sector between 2014 and 2019 have been analyzed, using confidential drug price information.

The researchers find that the coverage decisions are in line with the politically decided priority setting criteria, where a higher cost per QALY is accepted for more severe diseases. This is also valid for new cancer drugs.

Compared to drugs for less severe diseases, drugs for more severe diseases are approved with a higher cost per quality adjusted life gain. They also find that rejected drugs often have a much higher cost per QALY than approved drugs.

“There are many opinions about the system for appraising new drugs in Norway, and we hope our study can give an important contribution to this debate. We believe our findings are of international relevance too, as costly drugs and scarce resources are a challenge for all health systems globally”, says Tranvåg.



Journal

JAMA Network Open

DOI

10.1001/jamanetworkopen.2022.19503

Subject of Research

Not applicable

Article Title

Appraising Drugs Based on Cost-effectiveness and Severity of Disease in Norwegian Drug Coverage Decisions

Article Publication Date

29-Jun-2022

Tags: confidentialcoveragedecisionsdemonstrateDiseaseDrugimpactpricesseveritystudy
Share28Tweet17Share5ShareSendShare
  • Tulostoma shaihuludii and a ‘Shai-Hulud’

    Fungus from Arrakis: New species named after Dune’s giant worms

    77 shares
    Share 31 Tweet 19
  • Null results research now published by major behavioral medicine journal

    1154 shares
    Share 462 Tweet 289
  • New chemistry can extract virgin-grade materials from wind turbine blades in one process

    70 shares
    Share 28 Tweet 18
  • Scientists discover rare 6-planet system that moves in strange synchrony

    70 shares
    Share 28 Tweet 18
  • Acer i-Seed: the first eco-friendly fluorescent artificial seed for monitoring soil temperature by using drones

    70 shares
    Share 28 Tweet 18
  • Durable plastic pollution easily, cleanly degrades with new catalyst

    66 shares
    Share 26 Tweet 17
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Fungus from Arrakis: New species named after Dune’s giant worms

Collaboration between women helps close the gender gap in ice core science

Null results research now published by major behavioral medicine journal

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 208 other subscribers

© 2023 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2023 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In